Could a Cancer Protein Be at the Heart of Cardiac Scarring and Disease?
Research supported by the UR CTSI suggests that a tumor suppressor protein may play an important role in a heart rhythm disease and in cardiac scarring.
2021 Pilot Studies Investigate Breastmilk Fortifiers, Refine Therapies for Jaw Bone Loss, Dystonia
Our 2021 Pilot Awardees have just kicked off their new studies ranging from an investigation of new breast milk fortifiers for neonates to refining a stem-cell therapy for jaw bone loss and identifying biomarkers to streamline optimization of treatment for patients with dystonia.
UR CTSI Pilot Study Identifies Memory “Fingerprints”
UR CTSI-supported researchers are the first to observe and quantify the differences between how people reimagine common scenarios. These unique neurological “fingerprints” could ultimately be used to understand, study and even improve the treatment of disorders such as Alzheimer’s disease.
2020 Pilot Awards: Predicting Alzheimer’s, Heart Failure, Understanding Intellectual Disabilities
In July, three new pilot awardees began their UR CTSI-funded projects. Over the next year, the awardees will dissect the cellular and molecular causes of intellectual disabilities and develop new ways to predict Alzheimer's disease in seniors and heart failure in patients who need left ventricular assist devices (LVAD).
Just a Drop of Blood: An Easier Way to Test for COVID-19
UR CTSI Co-Director Martin Zand, M.D., Ph.D., is rapidly adapting previous flu research to develop a potential diagnostic test that would require just a few drops of blood to detect COVID-19 immunity.